AIm: To describe effectiveness of deep brain stimulation of subthalamic nucleus (DBS STN) on physical, emotional, cognitive functions and daily activities in Parkinson's patients. mAterIAl and methOds: Ten patients (51.20 ±10.20 yr.) were assessed three times. The Time Up and Go Test, 12 m Walking Test and Chair Stand Test were used to assess mobility and balance. Purdeu Pegboard and hand writing tests were used to evaluate hand function. The Hospital Anxiety and Depression Scale (HAD) was used to detect depressive symptoms and anxiety score. The Unified Parkinson\'s Disease Rating Scale (UPDRS) and Hoehn &Yahr Scale were also used. The Schwab and England Test was used to evaluate the daily activities (ADL).
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InTRoduCTIon
Parkinson's disease (PD) is a progressive movement disorder ensuing from dopaminergic depletion of the basal ganglia, substantia nigra pars compacta. The resulting disruption of the motor circuit that connects the basal ganglia to the motor cortex leads to the clinical manifestations of tremor, rigidity, bradykinesia and postural instability. The management of Parkinson's disease is mainly pharmacological. Levodopa and dopamine agonists are able to provide adequate symptomatic control in the first 5-10 years of therapy. However, long-term evolution is marred in the majority of patients by complications, such as fluctuations in the motor state and dyskinesias (16, 19) . In recent years, surgery has been revitalized for the treatment of patients with uncontrollable motor complications. The aim of surgery is mainly to decrease the pathological influences of abnormal neuronal drive from the subthalamic nucleus (STN) that characterize the Parkinsonian state. Deep brain stimulation (DBS) mimics the effect of lesions (thalamotomy, pallidotomy, etc.) with less risk of permanent neurological deficits (11). Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment to improve motor function, daily living activities and emotional status in patients with advanced Parkinson's disease. STN DBS, however, fails to address numerous symptoms that are disabling in advanced PD, such as levodopa-refractory axial motor disturbances. Several studies have shown a substantial beneficial effect of DBS of the STN in advanced Parkinson's disease 12-24 months post-operatively (13, 17, 23) . The other studies with respect to short-and long-term efficacy of STN-DBS have shown marked improvements in motor function as well as a reduction of antiparkinsonian drug treatment. Similar results have been reported in a smaller number of patients by a few other groups (8, 23) . The aim of this study was to describe the effects of deep brain stimulation of subthalamic nucleus (DBS STN) on physical, emotional, cognitive functions and daily living activities in patients with Parkinson's disease.
MATERIAL and METHodS
Patient Group
We studied 10 (5 male-5 female) consecutive patients who underwent bilateral stimulation of the subthalamic nucleus between January 2008 and January 2010. The selection criteria were clinically diagnosed Parkinson's disease, severe levodopa-related motor complications despite optimal adjustment of antiparkinsonian medication, no surgical contraindications, no dementia or major ongoing psychiatric illness and no other neurological disorders. The ethics committee of Pamukkale University in Turkey approved the study, and all the patients gave their written informed consent. The characteristics of the patients are summarized in Table I .
Surgery Procedure
All STN DBS procedures were performed by one neurosurgeon in two stages: (1) insertion of bilateral electrodes under local anaesthesia using microelectrode recording, and (2) connection of the electrodes to pulse generators under general anaesthesia, performed approximately 1 day after lead placement. The operative technique was described in details elsewhere (5) . The subthalamic nuclei were localized stereotactically by magnetic resonance imaging (MRI), and microelectrode recordings were performed to define STN. The quadripolar electrodes (Medtronic 37601 Activa PC) were implanted bilaterally in all patients. Surgery was performed with local anesthesia and clinical effect on rigidity and tremor was tested under stimulation using a macroelectrode. All patients underwent MRI postoperatively for the assessment of surgical complications. A programmable pulse generator was implanted subcutaneously under general anesthesia on the second day after implantation of the electrodes. Stimulation settings and medication were progressively adjusted.
Clinical Assessment
Patients were evaluated preoperatively and postoperatively at third and sixth months. Unblinded assessments were performed when patients had taken no medication for 8 to 12 hours (off medication) and during periods of maximal clinical benefit after the administration of a dose of liquid levodopa that was 50 percent higher than the usual morning dose of dopaminergic treatment (on medication). Postoperatively, patients were assessed during stimulation.
Outcome Measures
The physical therapist assessed the patient with clinical performance tests, and the same PT assessed all patients in all test situations.
The Timed Up & Go (TUG)
The subject sits in an armchair (seat height of 46 cm) with the back against the chair and arms resting on the chair's arms. The instruction "Go'' initiates the subject to stand up and walk at a comfortable pace to a line 3 meters away, where both feet should pass the line before the subject turns around and walks back to sit down again. Timing commences when the subject's back is leaving the back of the chair, and stops when the buttock reaches the seat of the chair. Average time required to complete the test TUG is reported (7).
Chair-Stand Test
The time required to stand up from a chair and to sit down five times consecutively as fast as possible is registered. The subject sits in an armchair (seat height of 46 cm) with the back against the chair, and with arms folded across the chest. The subject's regular footwear is worn. The test begins with the commando "Start now'' . Timing commence when the subject's back is leaving the back of the chair, and stops when the subject's buttock reaches the seat for the fifth time. One trial is performed. The average time required to complete the test is reported (7).
Meters Walking Test
The subject is standing still and then walks at a comfortable (preferred) speed straight forward. The subject's regular
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footwear is used. Timing commences after the command "Go'' and stops when the subject passes the mark for twelve meters. One trial is performed. The average time required to complete the test time is reported (7).
Unified Parkinson's Disease Rating Scale (UPDRS)
Patients were clinically assessed using the UPDRS. Different scores were extracted from this scale: the psychological status (items 1 and 4 of the UPDRS I), the daily living activities (ADL) score (items 5 and 17 of the UPDRS II), the motor score (items 18-31 of the UPDRS III), the dyskinesias score (items 32-35 of the UPDRS IV), the total UPDRS score comprised between 0 and 108, and the worst value was 108 (6).
Hoehn&Yahr Scale (H&Y)
H&Y is a commonly used system for describing how the symptoms of PD progress. The H&Y original scale included stages 1 through 5 with Stage 0: no signs of disease, stage 1: unilateral symptoms only, stage 2: bilateral symptoms and impairment of balance, stage 3: balance impairment, mild to moderate disease and physically independent, stage 4: severe disability, but still able to walk or stand unassisted, stage 5: needing a wheelchair or bedridden unless assisted (6).
Schwab and England Daily Living Activities Test (ADL)
The Schwab and England Test was used to evaluate the daily living activities (ADL). The test rates the patient's ability to perform ADL from 100% (essentially normal) to 0% (vegetative) (6) .
Purdeu Pegboard Test
The Purdue Pegboard test measures dexterity for two types of activity: one, involving the gross movement of arms, hands, and fingers and the other in primarily fingertip dexterity. The test consists of four parts: right hand, left hand, both hands and assembly. Their total is counted (20).
Hand Writing Tests
The sentence was selected and the writing task was performed using by dominant hand. Average time required to complete the test is reported.
Hospital Anxiety and Depression Scale (HAD)
HAD was applied to detect depressive symptoms and to describe anxiety score (10) .
Hodkinson Abbreviated Mental Test (AMT)
Cognitive performance was measured with AMT. AMT consisting of 10 questions to test time and place, orientation, memory and arithmetic skills (1).
All participants gave informed consent and the study was 
Statistical Analyses
Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS version 13.0). The Wilcoxon rank sum test was applied for comparison between the mean scores preoperatively and at the postoperative assessment. The effects of bilateral STN DBS on UPDRS, H&Y, ADL, HAD, AMT, hand function, mobility and balance assessment tests were analyzed using the paired t-test. A level of p<0.05 was considered significant.
RESuLTS
The demographics and clinical characteristics of patients at baseline are shown in Table I . The results of this study showed that all the patients' mobility and balance ability significantly improved at the third month and sixth month after surgery (p<0.05). The mobility and balance assessment values at the baseline, third month and sixth month are shown in Table II .
The hand function tests were significantly improved between the three assessments. Post hoc comparisons revealed that the comparison between preoperative and third month (p<0.05) and sixth month (p<0.05) were significant. The hand function tests are shown in Table III .
The anxiety and depression scores of thought disorders significantly decreased with month (p<0.05). Post hoc anxiety scores comparison revealed that differences were significant between before surgery and third month after surgery (P=0.000) and between before surgery and sixth month postop (P=0.003). Depressive symptoms score was found to be lower after surgery than before surgery (p<0.05). Compared to the preoperative period, third month and sixth month mental status scores were not significantly different (p>0.05). Mood status score and mental status score are shown in Table IV. Compared to the preoperative baseline, third month and sixth month score; the UPDRS-I, II, III, and IV scores in both the 'on' and 'off' states were significantly better (p<0.05). All aspects of the motor symptoms including speech, tremor, rigidity, and postural stability were significantly improved after surgery (p<0.05). Compared to the preoperative, third month and sixth month; the ADL scores were significantly better (p<0.05). At 6 months after surgery, the ADL score was increased from 20.60±1.64 to 60.83±2.85 (Paired t-test) (p<0.05). H&Y score was decreased from 4.20 ± 0.63 to 2.33 ± 1.50 at sixth month postop. Levodopa equivalents intake (LED) was reduced from a mean of 445. 00 ± 369. 27 to 208. 33 ± 281.36 mg/day after six months. Compared to the preoperative, third month and sixth month; the UPDRS total scores were significantly improved (p=0.000) ( Table V) .
dISCuSSIon
In patients with advanced Parkinson's disease who were followed prospectively, six month bilateral stimulation of the subthalamic nucleus led to significant postoperative improvements in all parkinsonian motor signs that were assessed. STN DBS is superior to best medical therapy in (18) . In our results, LED was reduced from a mean of 445.00 ± 369.27 to 208.33 ± 281.36 mg/day after six months.
Postural instability is one of the cardinal symptoms of Parkinson's disease (PD), and persons with PD have an increased risk of falling. Most falls occur during functional activities, e.g. walking and turning (12). STN DBS provides significant motor improving motor function, emotional status and daily living activities in PD patients with motor complications. The improvements over baseline were sustained six months after surgery (14) . STN stimulation has consistently been shown to attenuate the motor symptoms of PD and to decrease the daily dosage of medication, thus reducing drug related motor complications and according to some reports (3). Rodriguez Oroz et al., found that STN stimulation daily dosage (4) . In this study, the AMT score was not significantly different at six months after surgery.
DBS (STN-S)
is an effective treatment for functional capacity in PD. The Schwab and England scale has been used in other studies to assess the effects of surgical treatment in patients with PD in both the on-medication and off-medication states. Deep-brain stimulation of the thalamus has resulted in longterm improvement in tremor and activities of daily living. In the STN-S group, all disability indicated that improvement at twelfth month as measured by a decrease in the UPDRS-ADL score of 52% (p<0.001) with respect to the preoperative value. The FIM score increased after surgery by about 8% from baseline (2) . In another study, the patients' scores at five years for motor function while off medication improved by 54% compared with the baseline (P<0.001) and those for activities of daily living improved by 49% (P<0.001) (9). Tir et al. reported a decrease by 43% in the Unified Parkinson's Disease Rating Scale Part III score twelve months after surgery while the Unified Parkinson's Disease Rating Scale Part II score (activities of daily living) decreased by 34%, and the severity of dyskinesia-related disability decreased by 61% (22) . Our results are in line with the literature. UPDRS scores significantly decreased six months after surgery. Speech, tremor, rigidity and postural stability were significantly improved after surgery (p<0.05). At 6 months after surgery, the ADL score was increased from 20.60±1.64 to 60.83±2.85 (p<0.05). The H&Y score and LED were significantly decreased after six months (p<0.05). Depressive symptoms decreased by 78% six months after surgery. ADL and UPDRS motor and total scores improved by 190%, 72%, 78% respectively.
ConCLuSIon
Our study shows that selected patients with advanced PD benefit significantly from chronic STN neuromodulation,
